Catalytic covalent inhibition of cyclooxygenase-1 by a biomimetic acyltransferase
Authors:
Open Access
- 27 August 2022
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 72, 116973
Abstract
No abstract availableKeywords
Funding Information
- Delaware Biotechnology Institute
- National Institutes of Health
- National Institute of General Medical Sciences (5P30GM110758-02, P20GM104316)
This publication has 23 references indexed in Scilit:
- Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxibJournal of Lipid Research, 2013
- Chemical Cell-Surface Receptor Engineering Using Affinity-Guided, Multivalent OrganocatalystsJournal of the American Chemical Society, 2011
- The resurgence of covalent drugsNature Reviews Drug Discovery, 2011
- Measurement of cyclooxygenase inhibition using liquid chromatography–tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2011
- Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transferNature Chemical Biology, 2010
- An improved LC–MS/MS method for the quantification of prostaglandins E2 and D2 production in biological fluidsAnalytical Biochemistry, 2008
- Target-Specific Chemical Acylation of Lectins by Ligand-Tethered DMAP CatalystsJournal of the American Chemical Society, 2007
- Mechanistic Basis of Enzyme-Targeted DrugsBiochemistry, 2005
- Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine KinasesJournal of Medicinal Chemistry, 1997
- Induction of cyclo‐oxygenase‐2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasoneBritish Journal of Pharmacology, 1994